OXGENE™ accelerates therapy discovery and production, while improving accessibility to manufacturers and patients

Business Description

OXGENE™ has leading expertise in gene therapy, gene editing and antibody discovery. Its expert teams excel in mammalian cell engineering solutions, coupled with bioinformatics and automation to build robust and efficient biotechnology solutions. OXGENE™ is a trading name of Oxford Genetics LTD

Rationale for Investment

Opportunity to be a leading developer, supplier and licensor of a catalogue of synthetic biology technologies (plasmids, cell lines, kits) and products (viral, gene editing, antibody)